Atlas Trials

Sirolimus, Docetaxel, and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

Clinical trial NCT02565901 · TERMINATED

Trial details

NCT number
NCT02565901
Sponsor
University of Washington
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Castration-Resistant Prostate CarcinomaMetastatic Prostate CarcinomaStage IV Prostate Cancer AJCC v7Metastatic Malignant Neoplasm in the Bone
Start date
2016-02-29
Primary completion
2020-06-16
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.